Fatty Acid Binding Protein 1 is an Independent Prognostic Biomarker for Gallbladder Cancer with Direct Hepatic Invasion. | Fatty Acid Binding Protein 1 is an Independent Prognostic Biomarker for Gallbladder Cancer with Direct Hepatic Invasion. Qiu S, Liu Z, Hu J, Wang Z, Yue Z, Jia Z, Zhang W, Xue Z, Liu Z, Liu Y., Free PMC Article | 04/18/2024 |
Unravelling the role of urinary liver-type fatty acid binding protein in histone-induced AKI. | Unravelling the role of urinary liver-type fatty acid binding protein in histone-induced AKI. Lin LC, Wu VC. | 02/21/2024 |
Derlin-1 ameliorates nonalcoholic hepatic steatosis by promoting ubiquitylation and degradation of FABP1. | Derlin-1 ameliorates nonalcoholic hepatic steatosis by promoting ubiquitylation and degradation of FABP1. You H, Wen X, Wang X, Zhu C, Chen H, Bu L, Zhang J, Qu S. | 10/4/2023 |
Association between the rs2241883 polymorphism of the fatty acid-binding protein-1 (FABP1) gene and obesity in a population of MASHAD study cohort. | Association between the rs2241883 polymorphism of the fatty acid-binding protein-1 (FABP1) gene and obesity in a population of MASHAD study cohort. Valizadeh M, Aghasizadeh M, Shaghi F, Moradi A, Afshari HST, Zare-Feyzabadi R, Saberi-Karimian M, Hashemi M, Doust FNS, Nematy M, Bahre EA, Aghaei-Bakhtiari SH, Ghazizadeh H, Safarian-Bana H, Shabani N, Esmaily H, Ferns GA, Pasdar A, Ghayour-Mobarhan M., Free PMC Article | 07/19/2023 |
Fatty acid binding protein 1 (FABP1) and fatty acid binding protein 2 (FABP2) as a link between diabetic nephropathy and subclinical atherosclerosis in children and adolescents with type 1 diabetes. | Fatty acid binding protein 1 (FABP1) and fatty acid binding protein 2 (FABP2) as a link between diabetic nephropathy and subclinical atherosclerosis in children and adolescents with type 1 diabetes. Abo El-Asrar M, Ismail EAR, Elnhrawy AM, Thabet RA. | 03/7/2023 |
Associations of ANGPTL6, DOCK6, FABP1, and PCSK9 single-nucleotide variants with hypercholesterolemia in the Polish population: a cross-sectional study. | Associations of ANGPTL6, DOCK6, FABP1, and PCSK9 single-nucleotide variants with hypercholesterolemia in the Polish population: a cross-sectional study. Świderska MK, Mostowska A, Skrypnik D, Bogdański P, Jagodziński PP, Grzegorzewska AE. | 03/1/2023 |
Intestinal peroxisome proliferator-activated receptor alpha-fatty acid-binding protein 1 axis modulates nonalcoholic steatohepatitis. | Intestinal peroxisome proliferator-activated receptor α-fatty acid-binding protein 1 axis modulates nonalcoholic steatohepatitis. Yan T, Luo Y, Yan N, Hamada K, Zhao N, Xia Y, Wang P, Zhao C, Qi D, Yang S, Sun L, Cai J, Wang Q, Jiang C, Gavrilova O, Krausz KW, Patel DP, Yu X, Wu X, Hao H, Liu W, Qu A, Gonzalez FJ., Free PMC Article | 01/14/2023 |
FABP1 expression in human tumors: a tissue microarray study on 17,071 tumors. | FABP1 expression in human tumors: a tissue microarray study on 17,071 tumors. Dum D, Ocokoljic A, Lennartz M, Hube-Magg C, Reiswich V, Höflmayer D, Jacobsen F, Bernreuther C, Lebok P, Sauter G, Luebke AM, Burandt E, Marx AH, Simon R, Clauditz TS, Minner S, Menz A, Büscheck F, Gorbokon N, Steurer S, Blessin NC, Krech T., Free PMC Article | 01/11/2023 |
Downregulation of PPARalpha mediates FABP1 expression, contributing to IgA nephropathy by stimulating ferroptosis in human mesangial cells. | Downregulation of PPARα mediates FABP1 expression, contributing to IgA nephropathy by stimulating ferroptosis in human mesangial cells. Wu J, Shao X, Shen J, Lin Q, Zhu X, Li S, Li J, Zhou W, Qi C, Ni Z., Free PMC Article | 10/1/2022 |
FABP1 Gene Variant is Associated with Risk of Metabolic Syndrome. | FABP1 Gene Variant is Associated with Risk of Metabolic Syndrome. Zare-Feyzabadi R, Mozaffari M, Ghayour-Mobarhan M, Valizadeh M. | 06/25/2022 |
The association between a Fatty Acid Binding Protein 1 (FABP1) gene polymorphism and serum lipid abnormalities in the MASHAD cohort study. | The association between a Fatty Acid Binding Protein 1 (FABP1) gene polymorphism and serum lipid abnormalities in the MASHAD cohort study. Valizadeh M, Aghasizadeh M, Nemati M, Hashemi M, Aghaee-Bakhtiari SH, Zare-Feyzabadi R, Esmaily H, Ghazizdaeh H, Sahebi R, Ahangari N, Ferns GA, Pasdar A, Ghayour-Mobarhan M. | 02/19/2022 |
Pathophysiological and diagnostic importance of fatty acid-binding protein 1 in heart failure with preserved ejection fraction. | Pathophysiological and diagnostic importance of fatty acid-binding protein 1 in heart failure with preserved ejection fraction. Harada T, Araki T, Sunaga H, Kagami K, Yoshida K, Kato T, Kawakami R, Tomono J, Wada N, Iso T, Kurabayashi M, Obokata M., Free PMC Article | 01/29/2022 |
Fatty Acid-Binding Protein 1 as a Potential New Serological Marker of Liver Status in Children With Wilson Disease. | Fatty Acid-Binding Protein 1 as a Potential New Serological Marker of Liver Status in Children With Wilson Disease. Bierła JB, Jańczyk W, Konopka E, Wierzbicka-Rucińska A, Więckowski S, Obrycki Ł, Sarnecki J, Kanarek E, Cukrowska B, Socha P. | 10/30/2021 |
Association of macro-and micro-nutrients dietary intakes with rs2241883 genetic variants of FABP 1 gene in MASHAD study population. | Association of macro-and micro-nutrients dietary intakes with rs2241883 genetic variants of FABP 1 gene in MASHAD study population. Valizadeh M, Aghasizadeh M, Saberi-Karimian M, Safari M, Rohban M, Bana HS, Zare-Feyzabadi R, Tavakkol Afshari HS, Moradi A, Ahangari N, Hashemi M, Nematy M, Bahre EA, Aghaei-Bakhtiari SH, Ghazizadeh H, Esmaily H, Ferns GA, Pasdar A, Ghayour-Mobarhan M. | 10/23/2021 |
The Role of Elevated Liver-Type Fatty Acid-Binding Proteins in Liver Diseases. | The Role of Elevated Liver-Type Fatty Acid-Binding Proteins in Liver Diseases. Eguchi A, Iwasa M. | 10/16/2021 |
Mechanistic Investigation on the Regulation of FABP1 by the IL-6/miR-603 Signaling in the Pathogenesis of Hepatocellular Carcinoma. | Mechanistic Investigation on the Regulation of FABP1 by the IL-6/miR-603 Signaling in the Pathogenesis of Hepatocellular Carcinoma. Lin YX, Wu XB, Zheng CW, Zhang QL, Zhang GQ, Chen K, Zhan Q, An FM., Free PMC Article | 09/25/2021 |
Prognostic impact of elevated fatty acid-binding protein 1 in patients with heart failure. | Prognostic impact of elevated fatty acid-binding protein 1 in patients with heart failure. Kagami K, Sunaga H, Sorimachi H, Harada T, Yoshida K, Kato T, Kurosawa K, Kawakami R, Koitabashi N, Iso T, Adachi T, Kurabayashi M, Obokata M., Free PMC Article | 07/24/2021 |
FABP1 and FABP2 as markers of diabetic nephropathy. | FABP1 and FABP2 as markers of diabetic nephropathy. Tsai IT, Wu CC, Hung WC, Lee TL, Hsuan CF, Wei CT, Lu YC, Yu TH, Chung FM, Lee YJ, Wang CP., Free PMC Article | 07/10/2021 |
HIF1alpha-Regulated Expression of the Fatty Acid Binding Protein Family Is Important for Hypoxic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus. | HIF1α-Regulated Expression of the Fatty Acid Binding Protein Family Is Important for Hypoxic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus. Singh RK, Bose D, Robertson ES., Free PMC Article | 06/19/2021 |
Elevated Serum Liver-Type Fatty Acid Binding Protein Levels in Non-acetaminophen Acute Liver Failure Patients with Organ Dysfunction. | Elevated Serum Liver-Type Fatty Acid Binding Protein Levels in Non-acetaminophen Acute Liver Failure Patients with Organ Dysfunction. Karvellas CJ, Speiser JL, Tremblay M, Lee WM, Rose CF, US Acute Liver Failure Study Group. | 04/24/2021 |
Study of FABP's interactome and detecting new molecular targets in clear cell renal cell carcinoma. | Study of FABP's interactome and detecting new molecular targets in clear cell renal cell carcinoma. Wu G, Zhang Z, Tang Q, Liu L, Liu W, Li Q, Wang Q. | 02/6/2021 |
Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon. | Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon. Putra J, Ferrell LD, Gouw ASH, Paradis V, Rishi A, Sempoux C, Balabaud C, Thung SN, Bioulac-Sage P. | 01/30/2021 |
FABP1 controls hepatic transport and biotransformation of Delta(9)-THC. | FABP1 controls hepatic transport and biotransformation of Δ(9)-THC. Elmes MW, Prentis LE, McGoldrick LL, Giuliano CJ, Sweeney JM, Joseph OM, Che J, Carbonetti GS, Studholme K, Deutsch DG, Rizzo RC, Glynn SE, Kaczocha M., Free PMC Article | 10/24/2020 |
Novel Urinary Biomarkers for Acute Kidney Injury and Prediction of Clinical Outcomes After Pediatric Cardiac Surgery. | Novel Urinary Biomarkers for Acute Kidney Injury and Prediction of Clinical Outcomes After Pediatric Cardiac Surgery. Yoneyama F, Okamura T, Takigiku K, Yasukouchi S. | 09/19/2020 |
The data indicated that FABP1 impacts hepatocyte EC levels by binding EC and differentially impacts their intracellular hydrolysis (2-AG) and uptake (AEA). | Impact of Fabp1 Gene Ablation on Uptake and Degradation of Endocannabinoids in Mouse Hepatocytes. McIntosh AL, Huang H, Landrock D, Martin GG, Li S, Kier AB, Schroeder F. | 06/22/2019 |